TY - JOUR
T1 - Glomerular aging in females is a multi-stage reversible process mediated by phenotypic changes in progenitors
AU - Feng, Zheng
AU - Plati, Anna Rita
AU - Cheng, Qing Li
AU - Berho, Mariana
AU - Banerjee, Anita
AU - Potier, Mylene
AU - Jy, Wen Che
AU - Koff, Andrew
AU - Striker, Liliane J.
AU - Striker, Gary E.
N1 - Funding Information:
Supported by the National Institutes of Health ( National Institutes of Diabetes and Digestive and Kidney Diseases grant DK64118-01 to F.Z. and National Institute on Aging grants AG-19366-04 to G.E.S. and AG-17170-04 to L.J.S.), the National Kidney Foundation (fellowship to A.R.P.), and Genzyme (to F.Z.).
PY - 2005/8
Y1 - 2005/8
N2 - The glomeruli of postmenopausal C57BL6 mice, and age-matched, males, show progressive hypertrophy and glomerulosclerosis. We asked whether this was a multistage process, was due to alterations in glomerular progenitors, and was reversible in female mice. Using cross bone marrow transplants (BMT) between young and old females, we found that BMT delivered a phenotype that was donor age-specific. The fact that lesions in young recipients were more severe if the donors were in late rather than early menopause suggested that new progenitor phenotypes had appeared. Postmenopausal recipients of BMT from young donors had reduced glomerular hypertrophy and sclerosis, implying that the aging lesions in females were reversible and that progenitors, rather than the local environment, determined the glomerular profile. The altered phenotype included increased extracellular matrix synthesis and decreased matrix metalloproteinase-2 levels as well as cell hypertrophy. The mechanism of the cellular hypertrophy was due to uncoupling of hypertrophy from proliferation, resulting from elevated p27 levels. Thus, glomerular hypertrophy and sclerosis in aging females is a multistage process, is reversible, and may be determined by the phenotype of bone marrow-derived progenitor cells.
AB - The glomeruli of postmenopausal C57BL6 mice, and age-matched, males, show progressive hypertrophy and glomerulosclerosis. We asked whether this was a multistage process, was due to alterations in glomerular progenitors, and was reversible in female mice. Using cross bone marrow transplants (BMT) between young and old females, we found that BMT delivered a phenotype that was donor age-specific. The fact that lesions in young recipients were more severe if the donors were in late rather than early menopause suggested that new progenitor phenotypes had appeared. Postmenopausal recipients of BMT from young donors had reduced glomerular hypertrophy and sclerosis, implying that the aging lesions in females were reversible and that progenitors, rather than the local environment, determined the glomerular profile. The altered phenotype included increased extracellular matrix synthesis and decreased matrix metalloproteinase-2 levels as well as cell hypertrophy. The mechanism of the cellular hypertrophy was due to uncoupling of hypertrophy from proliferation, resulting from elevated p27 levels. Thus, glomerular hypertrophy and sclerosis in aging females is a multistage process, is reversible, and may be determined by the phenotype of bone marrow-derived progenitor cells.
UR - http://www.scopus.com/inward/record.url?scp=25144453517&partnerID=8YFLogxK
U2 - 10.1016/S0002-9440(10)62981-1
DO - 10.1016/S0002-9440(10)62981-1
M3 - Article
C2 - 16049323
AN - SCOPUS:25144453517
SN - 0002-9440
VL - 167
SP - 355
EP - 363
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 2
ER -